Ignite Creation Date:
2025-12-25 @ 4:43 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
Study NCT ID:
NCT06033118
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-13
First Post:
2023-07-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC
Sponsor:
Sichuan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-10
First Submit QC Date:
None
Study First Post Date:
2023-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-10
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL